Dr Adhya Mehta Department of Medicine

Slides:



Advertisements
Similar presentations
Latha G. Stead, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.
Advertisements

Suhyla Alam (Eastern Virginia Medical School), Amy West, Maura Downey, Jane EB Reusch, Kristen Nadeau University of Colorado Denver and Children’s Hospital.
Researcher: Dr Jayvant V Bhagattjee Supervisors: Prof Rashid Bhikha; Dr Yumna Abrahams Date: 24 September 2011.
Australian Commission on Safety and Quality in Health Care
Presented by Dr. Soe Sandi Tint
Marta Alves, Celestino Neves, Ana Varela, Cristina Arteiro, Luís Miguel Pereira, Davide Carvalho, José Luís Medina. Endocrinology Service, S. João Hospital,
+ Analysis of Physiological Outcomes in Patients with Type 2 Diabetes Through the Understanding of the Self-Care Model Daring to Defy Diabetes: Christina.
Agenda Introduction to established biomarker, HbA1c Objectives
TEMPLATE DESIGN © CONTINUOUS GLUCOSE MONITORING, ORAL GLUCOSE TOLERANCE, AND INSULIN – GLUCOSE PARAMETERS IN ADOLESCENTS.
Dr Zaranyika MBChB(Hons) UZ, MPH, FCP SA Department of Medicine UZ-CHS
Effect of a Community-Based Self-help Management Program for Patients with Diabetes Mellitus Effect of a Community-Based Self-help Management Program for.
1 Establishment of Blood Glucose Monitoring System Using the Internet Diabetes Care 27:478–483, 2004 Long-Term effect of the Internet-Based Glucose Monitoring.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Bedside point of care glucose testing for improving inpatient care
Diabetes & Driving- DVLA rules
Frequency of Helicobacter Pylori Infection among Type II Diabetic and Non-Diabetics Patients with Functional Dyspepsia Hanan Mahmoud Fayed1 , Mohamed A.
DIABETES CARE IN AN ORTHOPAEDIC LED FOOT CLINIC
The Efficacy and Safety of the Low Intensity Ultrasound Treatment in Patients with Open Angle Glaucoma Hyoung Won Bae, Gong Je Seong, Chan Yun Kim Institute.
Sofija Zagarins1, PhD, Garry Welch1, PhD, Jane Garb2, MS
HbA1c before Ramadan (%)
Objectives & Standards
Management of Diabetes at the End of life: a case note audit
Actions Outcomes Resulting from Positive Hemoglobin A1C Screenings
Diabetes and Hypertension Health Screening in the Fresno Sikh Population: A Cross Sectional Approach Baljit Singh Dhesi 1,2 1University of California,
Bettina Berger1, Rainer Stange2, Andreas Michalsen2, David Martin 1,3
Antonelli D, Koren O. Rozner E. Turgeman Y.
Suri S, Sr Resident, LHMC & SSKH, New Delhi
Averroes Prize Dr M. Abou Elew (Egypt).
Copyright © 2004 American Medical Association. All rights reserved.
SCI-Diabetes and My Diabetes My Way
ASSOCIATION OF CLINICAL AND BIOCHEMICAL FACTORS WITH SERUM TESTOSTERONE LEVELS IN TYPE 2 DIABETIC MALES Ravi Kumar Meena, Debasish Chaudhury, Amita.
International Neurourology Journal 2013;17:
MELLITUS - A CROSS SECTIONAL OBSERVATIONAL STUDY
AUDIT OF RED BLOOD CELL TRANSFUSION PRACTICE IN THE ITU SETTING
Introduction Materials and Methods Results Conclusions
Early identification of subclinical alterations of blood pressure in adolescents with cardiovascular risk: type 1 diabetic patients versus overweight subjects.
Frailty and its association with conventional risk factors for CAD among elderly patients with acute coronary syndrome.
Presenter : For : Dr. Dhananjay Gupta API-DSC 2016
Statement of the problem Conclusion/recommendations
Endurance-type exercise combined with acipimox administration provides superior benefits for glycemic control compared with endurance-type exercise alone.
W.S.T. Swarnasri1, Noel P. Somasundaram2
FreeStyle Libre Glucose Monitoring System
Dominique Hansen, PhD, FESC
Using the AGP to Standardize Glucose Reporting
SCI-Diabetes and My Diabetes My Way
Hemoglobin A1c Targets for Glycemic Controls
Best Practices in Advanced Glucose Monitoring
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
George Dailey, MD  Mayo Clinic Proceedings 
This Scientific Poster Template Is Provided By MakeSigns
Incidence of CV Events in Subjects With T2D vs the Nondiabetic CAD Population
This Scientific Poster Template Is Provided By MakeSigns
This Scientific Poster Template Is Provided By MakeSigns
Modern Advances in Glucose Monitoring
This Scientific Poster Template Is Provided By MakeSigns
Advancements in Glucose Monitoring
Hypoglycemia: The Most Common Barrier to Effective Diabetes Management
This Scientific Poster Template Is Provided By MakeSigns
Campbell FM, et al. Pediatr Diabetes. 2018;19(7):1294–1301
This Scientific Poster Template Is Provided By MakeSigns
Add Author Names and Information
This Scientific Poster Template Is Provided By MakeSigns
Add Author Names and Information Include Department Names if Needed
This Scientific Poster Template Is Provided By MakeSigns
This Scientific Poster Template Is Provided By MakeSigns
Add Author Names and Information Include Department Names if Needed
This Scientific Poster Template Is Provided By MakeSigns
This Scientific Poster Template Is Provided By MakeSigns
PowerPoint 16:9 Screen Ratio Template *
Glucose levels must be monitored in patients receiving steroids for immunotherapy-related toxicity Title: Subtitle Risk Assessment of Hyperglycaemia Induced.
Presentation transcript:

Ambulatory glucose profile measurement- is it a practical tool for monitoring diabetes?  Dr Adhya Mehta Department of Medicine Lady Hardinge Medical College & SSK Hospital, New Delhi. Financial disclosure- nil Conflict of interest- nil

Introduction A1c- avg of last 3 mths AGP (Ambulatory Glucose Profile) new technology automatically records glucose every 15 min x 14 d, provides with estimated A1c of preceding 14 days episodes of hyperglycaemia episodes of hypoglycaemia Glycemic variability

Aim To assess whether information obtained by AGP can be practically used in our set-up Does it add to the information provided by laboratory-provided A1c values?

Methodology N = 50 T2DM ≥18 years of age Diabetes Clinic of SSKH (LHMC), New Delhi. Type of Study : Cross-sectional A1c determined using Alere Afinion™ AS100 Analyzer using capillary blood glucose Those with HbA1c <8%, were placed AGP using FreeStyle Libre Pro®.

Values of laboratory determined A1c were compared with that estimated by the AGP device. Patients were divided into two groups on the basis of their A1c levels- A1c <7% (controlled) A1c between 7-8% (uncontrolled). Average episodes of hyperglycaemia and hypoglycaemia were calculated for each group.

RESULTS

Results Laboratory-determined A1c had a significant correlation with A1c estimated by AGP (r=0.617, p=0.0028).

Avg duration of hyperglycaemia episodes- 13.53± 9% Controlled diabetes Avg duration of hyperglycaemia episodes- 13.53± 9% Avg duration of hypos were 8.13± 11.4% Uncontrolled diabetes Avg hypoglycaemia episodes were 3.34±5.84% None of these hypoglycaemic events were picked up on SMPG measurements by the subjects

AGP graphs from four T2 patients with A1c = 7.6 to 7.7%

Conclusion Estimated A1c on AGP correlates well with laboratory A1c However, importantly AGP provides additional information Asymptomatic hypoglycaemic events in well-controlled and uncontrolled patients hyperglycaemic events in well-controlled patients Identify therapeutic time points of intervention  

Study in JAPI Apr 2016 also re-enforces these points.